Is Becton, Dickinson and Company (BDXA) a Buy, Sell, or Hold?
NYSE : BDXA
Becton, Dickinson and Company
$59.24 USD
-$1.36 (-2.24%)
- Volume
- 6.15M
- Average Volume
- 0
- Market Capitalization
- $55.91B
- P/E Ratio
- 40.16
- Dividend Yield
- 2.36%
- Price Target
- Year High
- $64.12
- Year Low
- $49.07
- Day High
- —
- Day Low
- —
- Payout Ratio
- $1.04
- Current Ratio
- $0.94
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
50
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
43
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$97645
BDXA Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
BDXA Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Muhsin Bilal | officer: EVP & President Connected Care | 2026-07-01 | A-Award | 0 | 2026-07-06 |
| Muhsin Bilal | officer: EVP & President Connected Care | 2026-07-02 | F-InKind | 0 | 2026-07-06 |
| Feld Michael | officer: EVP, Chief Revenue Officer | 2026-06-26 | S-Sale | 152.8 | 2026-06-26 |
| Garrison Michael David | officer: EVP & Pres Med.Essntl&BioPharm | 2026-06-24 | S-Sale | 145.66 | 2026-06-25 |
| Sinha Manish | officer: EVP and Chief People Officer | 2026-06-22 | 0 | 2026-06-22 | |
| Sinha Manish | officer: EVP and Chief People Officer | 2018-11-26 | 167.25 | 2026-06-22 | |
| Sinha Manish | officer: EVP and Chief People Officer | 2019-11-26 | 178.94 | 2026-06-22 | |
| Sinha Manish | officer: EVP and Chief People Officer | 2020-11-26 | 188.63 | 2026-06-22 | |
| Sinha Manish | officer: EVP and Chief People Officer | 2021-11-26 | 168.13 | 2026-06-22 | |
| Sinha Manish | officer: EVP and Chief People Officer | 2022-11-26 | 181.15 | 2026-06-22 | |
| Sinha Manish | officer: EVP and Chief People Officer | 2023-11-26 | 178.86 | 2026-06-22 | |
| Sinha Manish | officer: EVP and Chief People Officer | 2024-11-26 | 179.49 | 2026-06-22 | |
| Sinha Manish | officer: EVP and Chief People Officer | 2025-11-26 | 168.49 | 2026-06-22 | |
| Garrison Michael David | officer: EVP & Pres Med.Essntl&BioPharm | 2026-06-10 | S-Sale | 151.48 | 2026-06-11 |
| Polen Thomas E Jr | director, officer: Chairman, CEO and President | 2026-06-01 | M-Exempt | 126.16 | 2026-06-03 |
| Polen Thomas E Jr | director, officer: Chairman, CEO and President | 2026-06-01 | S-Sale | 146.35 | 2026-06-03 |
| Polen Thomas E Jr | director, officer: Chairman, CEO and President | 2026-06-01 | D-Return | 146.15 | 2026-06-03 |
| Polen Thomas E Jr | director, officer: Chairman, CEO and President | 2026-06-01 | M-Exempt | 126.16 | 2026-06-03 |
| Menziuso Peter | officer: EVP and President, BDI | 2026-06-01 | A-Award | 0 | 2026-06-02 |
| Menziuso Peter | officer: EVP and President, BDI | 2026-06-01 | 0 | 2026-06-02 | |
| Feld Michael | officer: EVP, Chief Revenue Officer | 2026-05-26 | S-Sale | 147.35 | 2026-05-27 |
| Huffines Robert Luther | director | 2026-05-08 | A-Award | 0 | 2026-05-08 |
| Byington Carrie L | director | 2026-05-08 | A-Award | 0 | 2026-05-08 |
| Roque Vitor | officer: EVP & Chief Financial Officer | 2026-05-07 | A-Award | 0 | 2026-05-08 |
| Feld Michael | officer: EVP, Chief Revenue Officer | 2026-04-27 | S-Sale | 151.94 | 2026-04-28 |
| Neal Shana Carol | officer: EVP and Chief People Officer | 2026-04-06 | F-InKind | 0 | 2026-04-06 |
| Feld Michael | officer: EVP, Chief Revenue Officer | 2026-03-26 | S-Sale | 156.83 | 2026-03-27 |
| Minnix Lanesha | officer: EVP and General Counsel | 2026-03-16 | A-Award | 0 | 2026-03-17 |
| Minnix Lanesha | officer: EVP and General Counsel | 2026-03-16 | 0 | 2026-03-17 | |
| Roque Vitor | officer: Interim CFO | 2026-03-02 | A-Award | 0 | 2026-03-04 |
| Spikner Pamela L. | officer: SVP Controller & CAO | 2026-03-02 | A-Award | 0 | 2026-03-04 |
| Feld Michael | officer: EVP, Chief Revenue Officer | 2026-02-26 | S-Sale | 181.84 | 2026-02-27 |
| SCOTT BERTRAM L | director | 2026-02-18 | S-Sale | 182.61 | 2026-02-18 |
| Urbini Massimiliano | officer: EVP & Chief ISC Officer | 2026-02-01 | 0 | 2026-02-06 | |
| Urbini Massimiliano | officer: EVP & Chief ISC Officer | 2024-11-26 | 238.89 | 2026-02-06 | |
| Urbini Massimiliano | officer: EVP & Chief ISC Officer | 2025-11-26 | 224.25 | 2026-02-06 | |
| Urbini Massimiliano | officer: EVP & Chief ISC Officer | 2022-11-26 | 241.1 | 2026-02-06 | |
| Urbini Massimiliano | officer: EVP & Chief ISC Officer | 2023-11-26 | 238.06 | 2026-02-06 | |
| Huffines Robert Luther | director | 2026-02-04 | A-Award | 0 | 2026-02-05 |
| Byington Carrie L | director | 2026-02-04 | A-Award | 0 | 2026-02-05 |
| Jones Christopher Ian Montague | director | 2026-02-04 | A-Award | 0 | 2026-02-05 |
| Henderson Jeffrey William | director | 2026-01-27 | A-Award | 0 | 2026-01-29 |
| ECKERT R ANDREW | director | 2026-01-27 | A-Award | 0 | 2026-01-29 |
| Byington Carrie L | director | 2026-01-27 | A-Award | 0 | 2026-01-29 |
| HAYES GREGORY | director | 2026-01-27 | A-Award | 0 | 2026-01-29 |
| Brown William M | director | 2026-01-27 | A-Award | 0 | 2026-01-29 |
| Huffines Robert Luther | director | 2026-01-27 | A-Award | 0 | 2026-01-29 |
| Jones Christopher Ian Montague | director | 2026-01-27 | A-Award | 0 | 2026-01-29 |
| RING TIMOTHY M | director | 2026-01-27 | A-Award | 0 | 2026-01-29 |
| SCOTT BERTRAM L | director | 2026-01-27 | A-Award | 0 | 2026-01-29 |
| Waldstreicher Joanne | director | 2026-01-27 | A-Award | 0 | 2026-01-29 |
| Wright Jacqueline | director | 2026-01-27 | A-Award | 0 | 2026-01-29 |
| Feld Michael | officer: EVP, CRO & Pres. Life Sciences | 2026-01-26 | S-Sale | 202.73 | 2026-01-28 |
| Spikner Pamela L. | officer: SVP Controller & CAO | 2026-01-21 | F-InKind | 0 | 2026-01-23 |
| Garrison Michael David | officer: EVP & Pres Med.Essntl&BioPharm | 2026-01-15 | M-Exempt | 167.91 | 2026-01-16 |
| Garrison Michael David | officer: EVP & Pres Med.Essntl&BioPharm | 2026-01-15 | D-Return | 209 | 2026-01-16 |
| Garrison Michael David | officer: EVP & Pres Med.Essntl&BioPharm | 2026-01-15 | S-Sale | 209 | 2026-01-16 |
| Garrison Michael David | officer: EVP & Pres Med.Essntl&BioPharm | 2026-01-15 | S-Sale | 206.54 | 2026-01-16 |
| Garrison Michael David | officer: EVP & Pres Med.Essntl&BioPharm | 2026-01-15 | M-Exempt | 167.91 | 2026-01-16 |
| Shan David | officer: EVP and Chief ISC Officer | 2026-01-03 | F-InKind | 0 | 2026-01-06 |
| Feld Michael | officer: EVP, CRO & Pres. Life Sciences | 2025-12-26 | S-Sale | 196.08 | 2025-12-29 |
| Garrison Michael David | officer: EVP & Pres Med.Essntl&BioPharm | 2025-12-17 | S-Sale | 196.03 | 2025-12-17 |
| Roque Vitor | officer: Interim CFO | 2025-12-05 | 0 | 2025-12-11 | |
| Roque Vitor | officer: Interim CFO | 2019-11-26 | 238.16 | 2025-12-11 | |
| Roque Vitor | officer: Interim CFO | 2020-11-26 | 251.06 | 2025-12-11 | |
| Roque Vitor | officer: Interim CFO | 2021-11-26 | 223.77 | 2025-12-11 | |
| Roque Vitor | officer: Interim CFO | 2022-11-26 | 241.1 | 2025-12-11 | |
| Roque Vitor | officer: Interim CFO | 2023-11-26 | 238.06 | 2025-12-11 | |
| Roque Vitor | officer: Interim CFO | 2024-11-26 | 238.89 | 2025-12-11 | |
| Roque Vitor | officer: Interim CFO | 2025-11-26 | 224.25 | 2025-12-11 | |
| Roque Vitor | officer: Interim CFO | 2018-11-26 | 222.6 | 2025-12-11 | |
| Feld Michael | officer: EVP, CRO & Pres. Life Sciences | 2025-12-01 | S-Sale | 193.36 | 2025-12-02 |
| Wright Jacqueline | director | 2025-12-01 | A-Award | 0 | 2025-12-02 |
| Huffines Robert Luther | director | 2025-12-01 | A-Award | 0 | 2025-12-02 |
| Huffines Robert Luther | director | 2025-12-01 | 0 | 2025-12-02 | |
| Wright Jacqueline | director | 2025-12-01 | 0 | 2025-12-02 | |
| Mocherla Pavan Kumar | officer: EVP & President, Greater Asia | 2025-11-26 | A-Award | 0 | 2025-12-01 |
| Mocherla Pavan Kumar | officer: EVP & President, Greater Asia | 2025-11-26 | A-Award | 0 | 2025-12-01 |
| Shan David | officer: EVP and Chief ISC Officer | 2025-11-26 | A-Award | 0 | 2025-12-01 |
| Shan David | officer: EVP and Chief ISC Officer | 2025-11-26 | F-InKind | 0 | 2025-12-01 |
| Shan David | officer: EVP and Chief ISC Officer | 2025-11-26 | A-Award | 0 | 2025-12-01 |
| Neal Shana Carol | officer: EVP and Chief People Officer | 2025-11-26 | A-Award | 0 | 2025-12-01 |
| Neal Shana Carol | officer: EVP and Chief People Officer | 2025-11-26 | F-InKind | 0 | 2025-12-01 |
| Neal Shana Carol | officer: EVP and Chief People Officer | 2025-11-26 | A-Award | 0 | 2025-12-01 |
| Goette Roland | officer: EVP and President, EMEA | 2025-11-26 | A-Award | 0 | 2025-12-01 |
| Goette Roland | officer: EVP and President, EMEA | 2025-11-26 | F-InKind | 0 | 2025-12-01 |
| Goette Roland | officer: EVP and President, EMEA | 2025-11-26 | A-Award | 0 | 2025-12-01 |
| Garrison Michael David | officer: EVP & Pres Med.Essntl&BioPharm | 2025-11-26 | A-Award | 0 | 2025-12-01 |
| Garrison Michael David | officer: EVP & Pres Med.Essntl&BioPharm | 2025-11-26 | F-InKind | 0 | 2025-12-01 |
| Garrison Michael David | officer: EVP & Pres Med.Essntl&BioPharm | 2025-11-26 | A-Award | 0 | 2025-12-01 |
| Feld Michael | officer: EVP, CRO & Pres. Life Sciences | 2025-11-26 | A-Award | 0 | 2025-12-01 |
| Feld Michael | officer: EVP, CRO & Pres. Life Sciences | 2025-11-26 | F-InKind | 0 | 2025-12-01 |
| DelOrefice Christopher | officer: EVP & Chief Financial Officer | 2025-11-26 | A-Award | 0 | 2025-12-01 |
| DelOrefice Christopher | officer: EVP & Chief Financial Officer | 2025-11-26 | F-InKind | 0 | 2025-12-01 |
| Byrd Richard | officer: EVP & President Interventional | 2025-11-26 | A-Award | 0 | 2025-12-01 |
| Byrd Richard | officer: EVP & President Interventional | 2025-11-26 | F-InKind | 0 | 2025-12-01 |
| Byrd Richard | officer: EVP & President Interventional | 2025-11-26 | A-Award | 0 | 2025-12-01 |
| Muhsin Bilal | officer: EVP & President Connected Care | 2025-11-26 | A-Award | 0 | 2025-12-01 |
| Polen Thomas E Jr | officer: Chairman, CEO and President | 2025-11-26 | A-Award | 193.9 | 2025-12-01 |
| Polen Thomas E Jr | officer: Chairman, CEO and President | 2025-11-26 | A-Award | 0 | 2025-12-01 |